Download the 2015 Agenda


2015 Speakers Include:

Biostór Ireland
Peadar Mac Gabhann
Director
Biostór Ireland
Bayer Pharma AG
Arndt Schmitz
Head of Research Biobank
Bayer Pharma AG
LifeLines
Marcel Bruinenberg
Project Manager
LifeLines
Auria Biobank
Heli Salimen-Mankonen
Research Director
Auria Biobank
Sanofi
Anne Bahr
Privacy Officer
Sanofi
GlaxoSmithKline
Victoria Haggerson
Manager of Biological Sample Management
GlaxoSmithKline
MedImmune
Chris Christodoulou
Head of Laboratory Compliance
MedImmune
IDIBAPS
Anna Bosch-Comas
Facility Coordinator
IDIBAPS
CNIO
Francisco de Luna
Deputy Coordinator of the National Biobank Network
CNIO
Biobank Graz
Berthold Huppertz
CEO, Director
Biobank Graz
Auria Biobank, University of Turku
Olli Carpen
Professor of Biobank Research
Auria Biobank, University of Turku
Auria Biobank
Samu Kurki
Senior Scientist
Auria Biobank
INSERM
Georges Dagher
Research Director
INSERM
King's College London
Cheryl Gillet
Head of Biobanking
King's College London
Merck
Karina Bienfait
Principal Scientist
Merck
GlaxoSmithKline
John Spaull
Senior Scientific Investigator
GlaxoSmithKline
MedLawconsult
Evert-Ben van Veen
Partner and Senior Consultant
MedLawconsult
University College London
Anne Carter
Centre Director
University College London
Bayer Healthcare
Annika Fischer
Scientist
Bayer Healthcare

Ensure Biobank Growth with High Quality Samples, Effective Data Management, Knowledge Sharing and Compliance

Biobanks are acknowledged as a necessary and powerful resource for R&D with access to millions of samples and the associated data collected with them.

The level and consistency of sample quality can have a huge impact on the validity of research findings. It is therefore critical for biobanks to ensure the high quality of their samples. With many large scale studies acquiring samples across multiple biobanks, it has become essential for both the standard of sample quality and the data collected to be harmonised.

The 12th Annual Global Biobanking Summit addresses the issues of quality and data standards as well as processes and technologies implemented to ensure traceability. Download the brochure here for more details.

Don't miss out on the opportunity to join biobank leaders from GSK, Auria Biobank, Biobank Graz, Sanofi, Merck, CNIO and more for three influential days of case studies and interactive discussion sessions! Register here.

P.S. Take a look at our BRAND NEW focus day on biobank funding and sustainability


WHY YOU CAN'T AFFORD TO MISS THIS EVENT:

  • Explore the latest initiatives to harmonise sample quality and data standards with Anne Carter, UCL, and Georges Dagher, INSERM
  • Develop best practice to obtain samples globally and track consent with Karina Bienfait, Merck
  • Evaluate effective processses to ensure sample quality and integrity with Victoria Haggerson, GSK, and Cheryl Gillett, KCL
  • Increase sample utilisation and create a collaborative public-private partnership with Francisco de Luna, CNIO, and John Spaull, GSK

Testimonials Include:

“Excellent content - very valuable” National Cancer Institute
“Very nice presentations withspot on subjects. Very good sessions” Erasmus MC Tissue Bank
“In such a topically diverse area, IQPC delivered a top class agenda with speakers and delegates to match” Qiagen

Sponsors & Exhibitors
Media Partners

Resource Centre

Visit the Resource Center for complimentary industry related content!

Featured Content

Sponsorship Opportunity

Learn more about sponsor & exhibit opportunities

IDGA

Become a Pharma IQ Member and receive our weekly newsletter!

Quick Links